偏头痛的临床管理
Clinical Management of Migraine.
作者信息
Albanese Maria
机构信息
Regional Referral Headache Center, Neurology Unit, University Hospital Tor Vergata, 00133 Rome, Italy.
Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
出版信息
J Clin Med. 2022 Sep 4;11(17):5225. doi: 10.3390/jcm11175225.
Abstract
Migraine is one of the most frequent neurological and vascular disorders, with an estimated global prevalence of 14 [...].
摘要
偏头痛是最常见的神经血管疾病之一，全球估计患病率为14[……]
相似文献
1
Clinical Management of Migraine.偏头痛的临床管理
J Clin Med. 2022 Sep 4;11(17):5225. doi: 10.3390/jcm11175225.
2
Prevalence of Migraine in the Elderly: A Narrated Review.老年人偏头痛的患病率：叙述性综述。
Neuroepidemiology. 2019;52(1-2):104-110. doi: 10.1159/000494758. Epub 2019 Jan 9.
3
[Ways of optimizing the management of patients with migraine in Russia (resolution of the council of experts)].[俄罗斯偏头痛患者管理的优化方法（专家委员会决议）]
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6):124-128. doi: 10.17116/jnevro201811861124.
4
Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies.非洲偏头痛的患病率及其对神经负担的影响：基于社区研究的43年系统评价和荟萃分析
J Neurol Sci. 2014 Jul 15;342(1-2):1-15. doi: 10.1016/j.jns.2014.04.019. Epub 2014 Apr 24.
5
Migraine in metabolic syndrome.代谢综合征中的偏头痛
Neurologist. 2009 Mar;15(2):55-8. doi: 10.1097/NRL.0b013e31817781b6.
6
[Migraine epidemiological, clinical and therapeutic data].[偏头痛的流行病学、临床及治疗数据]
Biol Aujourdhui. 2019;213(1-2):35-41. doi: 10.1051/jbio/2019019. Epub 2019 Jul 5.
7
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家偏头痛和紧张型头痛负担，1990-2016 年：2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):954-976. doi: 10.1016/S1474-4422(18)30322-3.
8
Migraine and vascular risk factors in the elderly.老年人偏头痛与血管危险因素
Geriatr Gerontol Int. 2014 Jan;14(1):220-5. doi: 10.1111/ggi.12061. Epub 2013 May 6.
9
The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations.神经影像学在评估神经系统检查正常的偏头痛或慢性每日头痛儿童中的应用。
Headache. 2000 Sep;40(8):629-32. doi: 10.1046/j.1526-4610.2000.040008629.x.
10
Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.偏头痛患病率及治疗模式：全球偏头痛与佐米曲普坦评估调查
Headache. 2003 Jan;43(1):19-26. doi: 10.1046/j.1526-4610.2003.03004.x.
引用本文的文献
1
Poor Adherence to the Mediterranean Diet and Sleep Disturbances Are Associated with Migraine Chronification and Disability among an Adult Population in the Lazio Region, Italy.意大利拉齐奥地区成年人中，地中海饮食依从性差和睡眠障碍与偏头痛慢性化和残疾有关。
Nutrients. 2024 Jul 8;16(13):2169. doi: 10.3390/nu16132169.
2
Early Wearing-Off Effect of OnabotulinumtoxinA in Chronic Migraine: A Prospective Real-Life Study.A型肉毒毒素治疗慢性偏头痛的早期疗效减退：一项前瞻性真实世界研究
J Clin Med. 2023 Aug 17;12(16):5360. doi: 10.3390/jcm12165360.
3
Risk of Migraine after Traumatic Brain Injury and Effects of Injury Management Levels and Treatment Modalities: A Nationwide Population-Based Cohort Study in Taiwan.创伤性脑损伤后偏头痛的风险以及损伤管理水平和治疗方式的影响：台湾一项基于全国人口的队列研究
J Clin Med. 2023 Feb 15;12(4):1530. doi: 10.3390/jcm12041530.
本文引用的文献
1
Ditans: a new prospective for the therapy of migraine attack?二氢麦角胺：偏头痛发作治疗的新展望？
Neurol Sci. 2022 Sep;43(9):5709-5716. doi: 10.1007/s10072-022-06260-z. Epub 2022 Jul 11.
2
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.在意大利真实世界中使用加巴喷丁治疗的患者中从慢性偏头痛转为发作性偏头痛：为期 12 个月的观察性、纵向、队列多中心 GARLIT 经验。
J Neurol. 2022 Nov;269(11):5848-5857. doi: 10.1007/s00415-022-11226-4. Epub 2022 Jun 28.
3
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.欧洲头痛联合会关于使用靶向降钙素基因相关肽通路的单克隆抗体预防偏头痛的指南-2022 更新版。
J Headache Pain. 2022 Jun 11;23(1):67. doi: 10.1186/s10194-022-01431-x.
4
Gepants - a long way to cure: a narrative review.格帕茨——漫漫治愈路：一篇叙述性评论。
Neurol Sci. 2022 Sep;43(9):5697-5708. doi: 10.1007/s10072-022-06184-8. Epub 2022 Jun 2.
5
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study).依利格鲁司他治疗早发型家族性阿尔茨海默病的有效性和安全性：一项随机、双盲、安慰剂对照的 3 期临床试验（EMERGE 研究）
J Headache Pain. 2022 Apr 9;23(1):46. doi: 10.1186/s10194-022-01396-x.
6
Could the New Anti-CGRP Monoclonal Antibodies Be Effective in Migraine Aura? Case Reports and Literature Review.新型抗降钙素基因相关肽单克隆抗体对偏头痛性先兆是否有效？病例报告及文献综述
J Clin Med. 2022 Feb 24;11(5):1228. doi: 10.3390/jcm11051228.
7
Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions.降钙素基因相关肽在皮肤中的作用以及其他生理和病理生理功能。
Brain Behav Immun Health. 2021 Oct 5;18:100361. doi: 10.1016/j.bbih.2021.100361. eCollection 2021 Dec.
8
Inflammatory complications of CGRP monoclonal antibodies: a case series.CGRP 单克隆抗体的炎症性并发症：病例系列。
J Headache Pain. 2021 Oct 9;22(1):121. doi: 10.1186/s10194-021-01330-7.
9
When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?我们何时应将慢性病患者视为对靶向降钙素基因相关肽（CGRP）通路的单克隆抗体无反应者？
J Neurol. 2022 Feb;269(2):1032-1034. doi: 10.1007/s00415-021-10772-7. Epub 2021 Aug 28.
10
Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019.偏头痛仍是全球致残原因中的第二位，在年轻女性中则位居首位：全球疾病负担研究2019的结果。
J Headache Pain. 2020 Dec 2;21(1):137. doi: 10.1186/s10194-020-01208-0.
Zotero 插件